News Summary

Toronto-based digital health company Felix is expanding its offerings beyond on-demand prescriptions to include a new longevity testing program. This initiative aims to meet the growing demand for preventative healthcare as more Canadians seek options to monitor and enhance their health proactively. The program includes an annual test that evaluates over 35 biomarkers related to metabolic health, organ function, and other vital health indicators. Felix’s co-founder, Emma Stern, notes that the expansion addresses gaps in Canada’s healthcare system, where many lack access to primary care. The program’s development involved Ontario physician Dr. Melody Hui to ensure clinical soundness, and it is currently available in Ontario, British Columbia, and Saskatchewan. Felix has raised over $30 million from investors and sees future growth opportunities, particularly in weight management solutions as generic drug options become available.